RIM
CBP

Regent Investment Management’s CHINA BOTANIC PHARMACEUTICAL INC COM STK (NV) CBP Stock Holding History

Regent Investment Management’s Portfolio CBP Stock Details CBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-10,926
Closed – – 200
2014
Q3 		$0 Hold
10,926
– – ﹤0.01% 199
2014
Q2 		$0 Hold
10,926
– – ﹤0.01% 197
2014
Q1 		$0 Hold
10,926
– – ﹤0.01% 199
2013
Q4 		$0 Hold
10,926
– – ﹤0.01% 191
2013
Q3 		$0 Hold
10,926
– – ﹤0.01% 177
2013
Q2 		$0 Buy
+10,926
New – ﹤0.01% 160

Regent Investment Management's CBP Position: Q4 2014 in Review

Regent Investment Management sold out of CHINA BOTANIC PHARMACEUTICAL INC COM STK (NV) (CBP) in Q4 2014, closing a stake of 10,926 shares.

Regent Investment Management first reported a position in CBP in Q2 2013 and held it in 6 quarters. The position peaked at $0 in Q3 2014. 0 funds tracked by Wall St. Rank hold CBP as of Q4 2014.

  • Regent Investment Management reported no remaining CHINA BOTANIC PHARMACEUTICAL INC COM STK (NV) position as of Q4 2014 after selling out during the quarter.
  • Regent Investment Management sold 10,926 CHINA BOTANIC PHARMACEUTICAL INC COM STK (NV) shares in Q4 2014.
  • Regent Investment Management first reported a position in CHINA BOTANIC PHARMACEUTICAL INC COM STK (NV) in Q2 2013 and held it in 6 quarters.
  • Regent Investment Management's CHINA BOTANIC PHARMACEUTICAL INC COM STK (NV) position peaked at $0 in Q3 2014.
  • 0 funds tracked by Wall St. Rank held CHINA BOTANIC PHARMACEUTICAL INC COM STK (NV) as of Q4 2014.

Based on Regent Investment Management's 13F filing for Q4 2014, filed 14 Jan 2015.